A multi-model approach identifies ALW-II-41-27 as a promising therapy for osteoarthritis-associated inflammation and endochondral ossification

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Heliyon

Topics

Medicine

Pathology

Internal Medicine

Rheumatology

Pharmacology

Show all topics

DOI

10.1016/j.heliyon.2024.e40871